Depending on what sort of a camper you are, you might bring a flashlight, lantern and lighter (or matches) on most of your trips. Prometheus 1 combines all of those things in one modular system, along ...
Prometheus Biosciences, a Phase 1 biotech developing precision antibody therapies for IBD and related diseases, filed on Friday with the SEC to raise up to $125 million in an initial public offering.
Prometheus Biosciences, a Phase 1 biotech developing precision antibody therapies for IBD and related diseases, announced terms for its IPO on Monday. The San Diego, CA-based company plans to raise ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback